Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2

被引：0
|
作者：
Yuansheng Duan
Kai Yue
Beibei Ye
Peng Chen
Jin Zhang
Qinghua He
Yue Wu
Qingchuan Lai
Hong Li
Yansheng Wu
Chao Jing
Xudong Wang
机构：
[1] Tianjin’s Clinical Research Center for Cancer,Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and T
[2] Tianjin Medical University Cancer Institute and Hospital,Department of Bone and Soft Tissue Tumors
来源：
Cell Death & Disease | / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] EZH2 promotes oral squamous cell carcinoma initiation and progression through epigenetic silencing of FHL1
    Cao, Wei
    Chen, Wantao
    CANCER RESEARCH, 2012, 72
  • [22] miR-92b regulates the proliferation and apoptosis of head and neck squamous cell carcinoma through regulating the expression of EZH2
    Wang, Run
    Feng, Yao
    Xiao, Yuanyuan
    Xue, Gang
    Liu, Ningning
    Kong, Yu
    Yin, Xiangnan
    Chi, Nannan
    Yao, Zhenyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (08): : 5557 - 5566
  • [23] LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2
    Zhang, Chunhua
    Shao, Shasha
    Zhang, Yujian
    Wang, Liyang
    Liu, Jianzhong
    Fang, Fang
    Li, Peiquan
    Wang, Bo
    LIFE SCIENCES, 2020, 243
  • [24] PD-L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling
    Zheng, Anyuan
    Li, Fen
    Chen, Fuhai
    Zuo, Jingjing
    Wang, Lei
    Wang, Yongping
    Chen, Shiming
    Xiao, Bokui
    Tao, Zezhang
    ONCOLOGY REPORTS, 2019, 41 (05) : 2833 - 2843
  • [25] Tazemetostat, a Selective EZH2 Inhibitor, in Combination with Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 1 Trial
    Oppelt, Peter J.
    Puram, Sidharth V.
    Liu, Jingxia
    Ley, Jessica C.
    Adkins, Douglas
    CANCERS, 2025, 17 (03)
  • [26] Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2
    Wu, Yuanyuan
    Hu, Liwen
    Liang, Yan
    Li, Juan
    Wang, Kai
    Chen, Xuedan
    Meng, Hui
    Guan, Xingying
    Yang, Kang
    Bai, Yun
    MOLECULAR CANCER, 2017, 16
  • [27] Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2
    Yuanyuan Wu
    Liwen Hu
    Yan Liang
    Juan Li
    Kai Wang
    Xuedan Chen
    Hui Meng
    Xingying Guan
    Kang Yang
    Yun Bai
    Molecular Cancer, 16
  • [28] RETRACTION: LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2
    Zhang, Chunhua
    Shao, Shasha
    Zhang, Yujian
    Wang, Liyang
    Liu, Jianzhong
    Fang, Fang
    Li, Peiquan
    Wang, Bo
    LIFE SCIENCES, 2024, 357
  • [29] LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A
    Chen, Qi
    Wu, Kun
    Qin, Xing
    Yu, Youcheng
    Wang, Xu
    Wei, Kuijie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (02) : 1626 - 1639
  • [30] FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program
    Zhang, Ming
    Hoyle, Rosalie G.
    Ma, Zhikun
    Sun, Bo
    Cai, Weixin
    Cai, Hongshi
    Xie, Nan
    Zhang, Yadong
    Hou, Jinsong
    Liu, Xiqiang
    Chen, Demeng
    Kellogg, Glen E.
    Harada, Hisashi
    Sun, Yue
    Wang, Cheng
    Li, Jiong
    MOLECULAR THERAPY, 2021, 29 (08) : 2583 - 2600
12345